Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 12317
TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694826(US20240294550, Example 20)
Affinity DataIC50: 1.40nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694830(US20240294550, Example 31 | 3-(4-((R)-4,4-difluoro...)
Affinity DataIC50: 3.90nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694828(US20240294550, Example 29)
Affinity DataIC50: 4.5nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694829(US20240294550, Example 30)
Affinity DataIC50: 5.20nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694830(US20240294550, Example 31 | 3-(4-((R)-4,4-difluoro...)
Affinity DataIC50: 5.60nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694808(US20240294550, Example 3)
Affinity DataIC50: 5.90nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694834(US20240294550, Example 36)
Affinity DataIC50: 6.20nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694832(US20240294550, Example 34)
Affinity DataIC50: 7.60nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694819(US20240294550, Example 14)
Affinity DataIC50: 8nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694810(US20240294550, Example 5)
Affinity DataIC50: 8.20nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694811(US20240294550, Example 6)
Affinity DataIC50: 13.2nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694833(US20240294550, Example 35)
Affinity DataIC50: 15.3nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694817(US20240294550, Example 12)
Affinity DataIC50: 16.9nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694804(US20240294550, Example 1)
Affinity DataIC50: 17.4nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694818(US20240294550, Example 13)
Affinity DataIC50: 18nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694813(US20240294550, Example 8)
Affinity DataIC50: 18.4nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694809(US20240294550, Example 4)
Affinity DataIC50: 20.3nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694812(US20240294550, Example 7)
Affinity DataIC50: 21.4nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694821(US20240294550, Example 16)
Affinity DataIC50: 21.9nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694820(US20240294550, Example 15)
Affinity DataIC50: 22nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694816(US20240294550, Example 11)
Affinity DataIC50: 22.4nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694822(US20240294550, Example 17)
Affinity DataIC50: 32nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694807(US20240294550, Example 2)
Affinity DataIC50: 40.3nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694823(US20240294550, Example 18)
Affinity DataIC50: 50.8nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694824(US20240294550, Example 26)
Affinity DataIC50: 57.7nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694814(US20240294550, Example 9)
Affinity DataIC50: 79.2nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694827(US20240294550, Example 23)
Affinity DataIC50: 85.5nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694815(US20240294550, Example 10)
Affinity DataIC50: 145nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Littdd Medicines

US Patent
LigandPNGBDBM694825(US20240294550, Example 27)
Affinity DataIC50: 149nMAssay Description:This experiment adopted Homogeneous time-resolved fluorescence technology (HTRF ) of Cisbio Company for assay.Experiment method: buffers were prepare...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent